Table 4 Descriptive statistics of clinical parameters
Table 4 Descriptive statistics of clinical parameters
author: Diederik F M Hentenaar, Yvonne C M De Waal, Hans Strooker, Henny J A Meijer, Arie-Jan Van Winkelhoff, Gerry M Raghoebar | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
Table 4 Descriptive statistics of clinical parameters
Control
Test
T0 (n = 22)
T3 (n = 20)
T0 (n = 31)
T3 (n = 30)
Plaque
% of sites (SD)
% of implants (n)
4.5 (12.5)
13.6 (3)
10.0 (18.8)
25.0 (5)
4.0 (9.3)
16.1 (5)
2.5 (7.6)
9.7 (3)
BoP
% of sites (SD)
% of implants (n)
86.4 (18.5)
100 (22)
28.8 (35.6)
50 (10)
66.1 (29.3)
96.8 (30)
39.2 (31.3)
76.7 (23)
SoP
% of sites (SD)
% of implants (n)
22.7 (24.3)
54.5 (12)
5.0 (15.4)
10.0 (2)
30.7 (20.1)
80.6 (25)
8.3 (20.1)
20.0 (6)
Mean PPD
Mean (SD)
5.3 (1.1)
3.5 (1.5)
5.2 (1.1)
4.1 (1.6)
PPD ≥5 mm
% of sites (SD)
% of implants (n)
67.1 (26.0)
100 (22)
18.8 (30.2)
35.0 (7)
61.3 (22.2)
100 (31)
28.3 (33.9)
46.7 (14)
PPD ≥6 mm
% of sites (SD)
% of implants (n)
50.0 (27.8)
100 (22)
12.5 (26.3)
25.0 (5)
46.8 (26.4)
90.3 (28)
24.2 (33.1)
40.0 (12)
PPD ≥5 mm + BoP/SoP (same site)
% of sites (SD)
% of implants (n)
% of patients (n)
65.9 (26.2)
100 (22)
100 (14/14)
12.5 (25.0)
25.0 (5)
33.3 (4/12)
54.8 (22.7)
100 (31)
100 (14/14)
20.0 (29.7)
36.7 (11)
46.2 (6/13)
PPD ≥6 mm + BoP/SoP (same site)
% of sites (SD)
% of implants (n)
% of patients (n)
50.0 (27.8)
100 (22)
100 (14/14)
8.8 (20.3)
20.0 (4)
33.3 (4/12)
41.1 (24.6)
90.3 (28)
100 (14/14)
17.5 (28.7)
33.3 (10)
46.2 (6/13)
Serial posts:
-
Implant decontamination with phosphoric acid
-
Background : Implant decontamination with phosphoric acid
-
Methods : Implant decontamination with phosphoric acid
-
Interventions : Implant decontamination with phosphoric acid
-
Outcomes : Implant decontamination with phosphoric acid
-
Randomization : Implant decontamination with phosphoric acid
-
Statistical analysis : Implant decontamination with phosphoric acid
-
Results : Implant decontamination with phosphoric acid (1)
-
Results : Implant decontamination with phosphoric acid (2)
-
Discussion : Implant decontamination with phosphoric acid (1)
-
Discussion : Implant decontamination with phosphoric acid (2)
-
Discussion : Implant decontamination with phosphoric acid (3)
-
References : Implant decontamination with phosphoric acid
-
Table 1 Characteristics of included patients/implants
-
Table 2 Log-transformed mean bacterial anaerobic counts
-
Table 3 Log-transformed mean bacterial anaerobic counts
-
Table 4 Descriptive statistics of clinical parameters
-
Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
-
Figure 1. Flow diagram
Table 4 Descriptive statistics of clinical parameters
| Control | Test | ||||
|---|---|---|---|---|---|
| T0 (n = 22) | T3 (n = 20) | T0 (n = 31) | T3 (n = 30) | ||
| Plaque | % of sites (SD) % of implants (n) |
4.5 (12.5) 13.6 (3) |
10.0 (18.8) 25.0 (5) |
4.0 (9.3) 16.1 (5) |
2.5 (7.6) 9.7 (3) |
| BoP | % of sites (SD) % of implants (n) |
86.4 (18.5) 100 (22) |
28.8 (35.6) 50 (10) |
66.1 (29.3) 96.8 (30) |
39.2 (31.3) 76.7 (23) |
| SoP | % of sites (SD) % of implants (n) |
22.7 (24.3) 54.5 (12) |
5.0 (15.4) 10.0 (2) |
30.7 (20.1) 80.6 (25) |
8.3 (20.1) 20.0 (6) |
| Mean PPD | Mean (SD) | 5.3 (1.1) | 3.5 (1.5) | 5.2 (1.1) | 4.1 (1.6) |
| PPD ≥5 mm | % of sites (SD) % of implants (n) |
67.1 (26.0) 100 (22) |
18.8 (30.2) 35.0 (7) |
61.3 (22.2) 100 (31) |
28.3 (33.9) 46.7 (14) |
| PPD ≥6 mm | % of sites (SD) % of implants (n) |
50.0 (27.8) 100 (22) |
12.5 (26.3) 25.0 (5) |
46.8 (26.4) 90.3 (28) |
24.2 (33.1) 40.0 (12) |
| PPD ≥5 mm + BoP/SoP (same site) | % of sites (SD) % of implants (n) % of patients (n) |
65.9 (26.2) 100 (22) 100 (14/14) |
12.5 (25.0) 25.0 (5) 33.3 (4/12) |
54.8 (22.7) 100 (31) 100 (14/14) |
20.0 (29.7) 36.7 (11) 46.2 (6/13) |
| PPD ≥6 mm + BoP/SoP (same site) | % of sites (SD) % of implants (n) % of patients (n) |
50.0 (27.8) 100 (22) 100 (14/14) |
8.8 (20.3) 20.0 (4) 33.3 (4/12) |
41.1 (24.6) 90.3 (28) 100 (14/14) |
17.5 (28.7) 33.3 (10) 46.2 (6/13) |
- Implant decontamination with phosphoric acid
- Background : Implant decontamination with phosphoric acid
- Methods : Implant decontamination with phosphoric acid
- Interventions : Implant decontamination with phosphoric acid
- Outcomes : Implant decontamination with phosphoric acid
- Randomization : Implant decontamination with phosphoric acid
- Statistical analysis : Implant decontamination with phosphoric acid
- Results : Implant decontamination with phosphoric acid (1)
- Results : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (1)
- Discussion : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (3)
- References : Implant decontamination with phosphoric acid
- Table 1 Characteristics of included patients/implants
- Table 2 Log-transformed mean bacterial anaerobic counts
- Table 3 Log-transformed mean bacterial anaerobic counts
- Table 4 Descriptive statistics of clinical parameters
- Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
- Figure 1. Flow diagram